PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2020.12332021532291-300Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert OpinionChanghoon Yoo, Chung Ryul Oh, Seung-Tae Kim, Woo Kyun Bae, Hye-Jin Choi, Do-Youn Oh, Myung-Ah Lee, Baek-Yeol Ryoohttp://e-crt.org/upload/pdf/crt-2020-1233.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2020.1233, http://e-crt.org/upload/pdf/crt-2020-1233.pdf
Endocrine Practice10.4158/ep13262.ra2014202167-175Systemic Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS): Cuirrent Approaches and Future OptionsJonathan R. Strosberghttps://api.elsevier.com/content/article/PII:S1530891X20437486?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1530891X20437486?httpAccept=text/plain, http://aace.metapress.com/index/201873X814443875.pdf
International Journal of Surgical Oncology10.1155/2017/6424812201720171-14Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent LiteratureVladimir Neychev, Electron Kebebewhttp://downloads.hindawi.com/journals/ijso/2017/6424812.pdf, http://downloads.hindawi.com/journals/ijso/2017/6424812.xml, http://downloads.hindawi.com/journals/ijso/2017/6424812.pdf
Clinical Diabetes and Endocrinology10.1186/s40842-018-0066-3201841Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)Inbal Uri, Simona Grozinsky-Glasberghttp://link.springer.com/content/pdf/10.1186/s40842-018-0066-3.pdf, http://link.springer.com/article/10.1186/s40842-018-0066-3/fulltext.html, http://link.springer.com/content/pdf/10.1186/s40842-018-0066-3.pdf
Clinical and Experimental Gastroenterology10.2147/ceg.s5928201079Advances in the treatment of gastroenteropancreatic neuroendocrine tumorsGeorge Fisher, Kunzhttps://www.dovepress.com/getfile.php?fileID=6643
Gastroenterology10.1016/0016-5085(95)26173-719951084A465High-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumorshttps://api.elsevier.com/content/article/PII:0016508595261737?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0016508595261737?httpAccept=text/plain
Clinical Applications of Nuclear Medicine Targeted Therapy10.1007/978-3-319-63067-0_212018281-287Medical Treatment of Gastroenteropancreatic (GEP) Neuroendocrine TumorsCarlo Carnaghi, Valeria Smiroldohttp://link.springer.com/content/pdf/10.1007/978-3-319-63067-0_21
Cancers10.3390/cancers4010113201241113-129Medical Treatment of Gastroenteropancreatic Neuroendocrine TumorsAnja Rinke, Patrick Michl, Thomas Gresshttp://www.mdpi.com/2072-6694/4/1/113/pdf
Surgical Pathology Clinics10.1016/j.path.2019.08.01120191241045-1053Treatment of Gastroenteropancreatic Neuroendocrine TumorsKimberly Perez, Jennifer Chanhttps://api.elsevier.com/content/article/PII:S1875918119300674?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1875918119300674?httpAccept=text/plain
Virchows Archiv10.1007/s00428-007-0446-z2007451S171-80Treatment of gastroenteropancreatic neuroendocrine tumorsU. Plöckinger, B. Wiedenmannhttp://link.springer.com/content/pdf/10.1007/s00428-007-0446-z.pdf, http://link.springer.com/article/10.1007/s00428-007-0446-z/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00428-007-0446-z